88 related articles for article (PubMed ID: 2151769)
1. Monoclonal antibodies to CD3 as immunosuppressants.
Chatenoud L; Bach JF
Semin Immunol; 1990 Nov; 2(6):437-47. PubMed ID: 2151769
[TBL] [Abstract][Full Text] [Related]
2. Selective immunosuppression with anti-T cell monoclonal antibodies.
Chatenoud L; Bach JF
Clin Nephrol; 1992; 38 Suppl 1():S53-60. PubMed ID: 1295709
[TBL] [Abstract][Full Text] [Related]
3. In vivo T cell activation properties of anti-T cell monoclonal antibodies.
Ferran C; Bach JF; Chatenoud L
Exp Nephrol; 1993; 1(2):83-9. PubMed ID: 8081961
[TBL] [Abstract][Full Text] [Related]
4. In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growth.
Hirsch R; Ellenhorn JD; Bluestone JA
Princess Takamatsu Symp; 1988; 19():237-43. PubMed ID: 2978618
[TBL] [Abstract][Full Text] [Related]
5. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
[TBL] [Abstract][Full Text] [Related]
6. Effects of neonatal injections of anti-CD3 epsilon monoclonal antibodies on the T cell functions of adult mice.
Rueff-Juy D; Drapier AM; Cazenave PA
J Immunol; 1989 Jun; 142(11):3788-95. PubMed ID: 2523935
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3.
Ellenhorn JD; Hirsch R; Hartley JP; Bluestone JA
Transplant Proc; 1989 Feb; 21(1 Pt 1):1013-4. PubMed ID: 2523110
[No Abstract] [Full Text] [Related]
8. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
10. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
11. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
13. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
14. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the humoral response to anti-CD3 mAB by pretreatment with anti-CD4 mAB.
Hirsch R; Chatenoud L; Gress RE; Bach JF; Sachs DH; Bluestone JA
Transplant Proc; 1989 Feb; 21(1 Pt 1):1015-6. PubMed ID: 2523111
[No Abstract] [Full Text] [Related]
16. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
17. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
[TBL] [Abstract][Full Text] [Related]
20. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies.
Manger B; Weiss A; Imboden J; Laing T; Stobo JD
J Immunol; 1987 Oct; 139(8):2755-60. PubMed ID: 3116093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
